According to the government, Rashid Naqvi, a Houston-area resident, fraudulently sought $4.6 million from Medicare for COVID-19 test kits and obtained $2.0 million.
Lab test reimbursement cuts and price reporting requirements that were called for under the law will be delayed as part of the recently passed spending bill.
The company also expects to grant underwriters a 30-day option to purchase up to 15 percent of the ordinary shares being offered.